Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Accretion Pharmaceuticals Limited (NSE: ACCPL), ISIN INE0T8T01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ACCPL last traded at ₹205.00 (-4.65%), with a 52-week range of ₹53.80 to ₹219.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 73.52%, FIIs 0.00%, DIIs 2.76%, mutual funds 0.00%.
EquiSense Score (ECS): 48/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.